PATIENT ALERT: Masks are now optional in our VOA offices. If you are immunocompromised or feeling ill, masking is strongly encouraged. Thank you. CLICK HERE for more details.

Clinical Research & Trials

USO 21550

A Phase II multi-center, open-label, single-arm dose escalation study of Asciminib monotherapy in 2nd Line Chronic Phase - Chronic Myelogenous Leukemia (ASC2ESCALATE)(CABL001AUS08)

Disease Types: Lymphoma & Hematologic

Available at:

Norfolk (Brock Cancer Center)
Newport News (Port Warwick III)
Virginia Beach (Princess Anne)
Hampton (CarePlex)
Chesapeake

Treatment Options

Services

Support During Cancer

Cancers We Treat

Blood Cancers

Blood Disorders

Find a Provider Near You

Clinical Research & Trials

Listen to our podcast

USO 21550

A Phase II multi-center, open-label, single-arm dose escalation study of Asciminib monotherapy in 2nd Line Chronic Phase - Chronic Myelogenous Leukemia (ASC2ESCALATE)(CABL001AUS08)